BPC-157 10mg + TB-500 10mg

Regenesis Complex — BPC-157 10mg + TB-500 10mg Research Bundle UK

The Regenesis Complex pairs BPC-157 10mg and TB-500 10mg, the two most widely studied recovery research peptides in the UK research peptide market. The two compounds are mechanistically complementary rather than duplicative: BPC-157 is a synthetic pentadecapeptide (GEPPPGKPADDAGLV) investigated primarily through nitric oxide signalling and VEGF-related angiogenesis pathways, while TB-500 (Thymosin Beta-4 Fragment, Ac-LKKTETQ) acts through G-actin binding and cytoskeletal modulation. This mechanistic separation allows both compounds to function as independent variables within the same tissue or cellular research model, rather than overlapping on a single pathway.

Sourcing both compounds as a single-supplier bundle provides batch consistency across the research protocol — both peptides are tested against the same documentation standard by the same independent laboratory, simplifying record-keeping for multi-compound experimental designs.

Every compound in the Regenesis Complex is independently tested by Janoshik laboratory. HPLC purity is confirmed at ≥98%, with LC-MS molecular identity verification for both BPC-157 and TB-500. Batch-specific Certificates of Analysis are publicly accessible for both compounds before purchase.

For laboratory handling purposes, both lyophilised peptides may be reconstituted using BP-grade bacteriostatic water, added slowly down the inner vial wall and gently swirled to dissolve. Aliquot immediately and store at -20°C, avoiding repeated freeze-thaw cycles.

For complete mechanism detail on each compound, see the BPC-157 and TB-500 research guides on the Ascend Peptides UK blog, or the recovery research peptides category page for the full mechanistic comparison.

WADA Status: Both BPC-157 and TB-500 are listed on the WADA Prohibited List, prohibited at all times.

DISCLAIMER: For in-vitro laboratory research only. Not for human consumption, therapeutic, diagnostic, or clinical use. Not classified as a medicinal product by the MHRA.